AU1037301A - Therapy of cephalic pain - Google Patents

Therapy of cephalic pain

Info

Publication number
AU1037301A
AU1037301A AU10373/01A AU1037301A AU1037301A AU 1037301 A AU1037301 A AU 1037301A AU 10373/01 A AU10373/01 A AU 10373/01A AU 1037301 A AU1037301 A AU 1037301A AU 1037301 A AU1037301 A AU 1037301A
Authority
AU
Australia
Prior art keywords
therapy
cephalic pain
cephalic
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10373/01A
Inventor
Linda Catherine Mccarthy
Ian James Purvis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9924712.4A external-priority patent/GB9924712D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1037301A publication Critical patent/AU1037301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AU10373/01A 1999-10-19 2000-10-19 Therapy of cephalic pain Abandoned AU1037301A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16041899P 1999-10-19 1999-10-19
GB9924712 1999-10-19
GBGB9924712.4A GB9924712D0 (en) 1999-10-19 1999-10-19 Therapeutic method
US60160418 1999-10-19
PCT/GB2000/004051 WO2001028540A2 (en) 1999-10-19 2000-10-19 Agent for treating cephalic pain

Publications (1)

Publication Number Publication Date
AU1037301A true AU1037301A (en) 2001-04-30

Family

ID=26316011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10373/01A Abandoned AU1037301A (en) 1999-10-19 2000-10-19 Therapy of cephalic pain

Country Status (2)

Country Link
AU (1) AU1037301A (en)
WO (1) WO2001028540A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025678D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Diagnostic test
AU2003215007A1 (en) * 2002-02-06 2003-09-02 Exelixis, Inc. MINRs as modifiers of insulin receptor signaling and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
US5677279A (en) * 1996-12-16 1997-10-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treating pain with amylin or agonists thereof
GB9824614D0 (en) * 1998-11-11 1999-01-06 Glaxo Group Ltd Chemical compounds
US6204288B1 (en) * 1999-03-08 2001-03-20 The University Of Mississippi 1,2-dithiolane derivatives
GB9924717D0 (en) * 1999-10-19 1999-12-22 Glaxo Group Ltd Diagnostic

Also Published As

Publication number Publication date
WO2001028540A2 (en) 2001-04-26
WO2001028540A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
AU2751200A (en) Intrabody hifu applicator
AU3867400A (en) Methods of using bioelastomers
AU7906100A (en) Use of retigabin for treating neuropathic pain
AU3791601A (en) Treatment of coal
AU3891299A (en) Combination therapy for treatment of depression
AU3784999A (en) Methods for treatment of pain
AU1356201A (en) Treatment of hyperproliferative disorders
AU3896900A (en) Treatment of pain
AU2512501A (en) Use of trimebutine for treating pain
AU3082401A (en) Therapy of psoriasis
AU7106300A (en) Treatment of skin disorders
PL350850A1 (en) Method of providing cosmetic/medical therapy
AU1449501A (en) Iontophoretic treatment system
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU2566201A (en) Compounds and methods for the treatment of pain
AU1037301A (en) Therapy of cephalic pain
AU5646300A (en) Methods of stimulating angiogenesis
AU1405001A (en) Treatment of diseases
AU1618901A (en) Treatment of rosacea
AU4598400A (en) Method of treatment
AU5379200A (en) Bone stimulating factor
AU1036801A (en) Agent for treating cephalic pain
AU2420201A (en) Compounds and methods for the treatment of pain
AUPP860099A0 (en) Treatment of feeds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase